Article Text

Download PDFPDF
Improving safety and efficiency during emergent central venous catheter placement with a needleless securing clamp
  1. Bert Silich1,
  2. Paul Chrobak1,
  3. Jeffrey Siu1,
  4. Adam Schlichting1,2,
  5. Samir Patel1,
  6. James Yang2
  1. 1Department of Emergency Medicine, Henry Ford Health System, Detroit, Michigan, USA
  2. 2Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA
  1. Correspondence to Bert Silich, Department of Emergency Medicine, Henry Ford Health System, Henry Ford Hospital, West Bloomfield, 6777 West Maple Road, West Bloomfield, MI 48322, USA; bsilich1{at}hfhs.org

Abstract

Objective To compare the needleless securing clamp to the traditional suture-secured clamp for central venous catheters.

Methods Compare the holding strength of each type of clamps by measuring the amount of kinetic energy absorbed, ask 20 physicians to evaluate the clamp placement using sutures or staples, and summarise the clamps effectiveness and complications in 10 patients.

Results Compared to sutured clamp, the needleless clamp was more secure. The needleless clamp was also significantly better with regard to ease of use, safety, perceived strength (p value <0.002), and insertion time was reduced by 63%. No adverse events or skin infections occurred while using the needleless clamps.

Conclusions Without incurring complications or increasing risk to patients, the needleless clamp is secure and improves safety and efficiency for physicians.

  • Suture-secured clamp
  • needleless securing clamp
  • needlestick

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests The Needleless Catheter Clamp is patented by the Henry Ford Health System. Dr Silich is the sole inventor. The Henry Ford Health System and Dr Silich are eligible to receive royalty payments for the commercial use of this device.

  • Ethics approval Henry Ford Health System Institutional Review Board.

  • Provenance and peer review Not commissioned; externally peer reviewed.